Literature DB >> 2450879

Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases.

R Montesano1, M S Pepper, D Belin, J D Vassalli, L Orci.   

Abstract

We have previously shown that capillary endothelial cells grown on the surface of three-dimensional collagen gels can be induced to invade the underlying fibrillar matrix and to form capillary-like tubular structures in response to tumor-promoting phorbol esters or the angiogenic agent fibroblast growth factor (FGF). Since both phorbol esters and FGF stimulate phosphorylation of tyrosine residues, we treated endothelial cells with vanadate, an inhibitor of phosphotyrosine-specific phosphatases, to determine whether this agent could induce the expression of an angiogenic phenotype in these cells. We show here that vanadate stimulates endothelial cells to invade collagen matrices and to organize into characteristic tubules resembling those induced by FGF or phorbol esters. We have further observed that vanadate concomitantly stimulates endothelial cells to produce plasminogen activators (PAs), proteolytic enzymes which are induced by phorbol esters and FGF, and which have been implicated in the neovascular response; this stimulation can be accounted for by an increase in the levels of urokinase-type PA and tissue type PA mRNA. These results suggest a role for tyrosine phosphorylation in the regulation of the angiogenic phenotype in capillary endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450879     DOI: 10.1002/jcp.1041340318

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  ERKs activation and calcium signaling are both required for VEGF induction by vanadium in mouse epidermal Cl41 cells.

Authors:  Jingxia Li; Qiangsong Tong; Xianglin Shi; Max Costa; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

2.  Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid.

Authors:  R A Stoltz; M S Conners; M E Gerritsen; N G Abraham; M Laniado-Schwartzman
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

3.  Role of protein tyrosine phosphorylation in rat corneal neovascularization.

Authors:  A Hayashi; K S Popovich; H C Kim; E de Juan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-07       Impact factor: 3.117

4.  A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice.

Authors:  I J Polakowski; M K Lewis; V R Muthukkaruppan; B Erdman; L Kubai; R Auerbach
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

5.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

Authors:  T Fotsis; M Pepper; H Adlercreutz; G Fleischmann; T Hase; R Montesano; L Schweigerer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth.

Authors:  T Noguchi; R Metz; L Chen; M G Mattéi; D Carrasco; R Bravo
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Angiogenesis: role of calcium-mediated signal transduction.

Authors:  E C Kohn; R Alessandro; J Spoonster; R P Wersto; L A Liotta
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Glycosaminoglycans enhance phorbol ester-induced proteolytic activity and angiogenesis in vitro.

Authors:  D Y Wang; C H Kao; V C Yang; J K Chen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-11       Impact factor: 2.416

9.  Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.

Authors:  U O Wenzel; B Fouqueray; P Biswas; G Grandaliano; G G Choudhury; H E Abboud
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

Authors:  M Stoll; U M Steckelings; M Paul; S P Bottari; R Metzger; T Unger
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.